Search
-
CompanyNET PHARMA
-
-
-
EventISCT 2025
-
-
-
-
NewNanobots Therapeutics advances its development after securing the first million in its see...
The startup successfully completed the first stage of its seed investment round, raising €960,000 in private capital.
-
-
-
-
NewPoster presentation of Aula de Farmacovigilancia at ISoP Annual Meeting in Montreal 2024
PVpharm presented a poster communication about the Aula de Farmacovigilancia PVpharm Universidad de Granada at ISoP 23rd annual meeting in Montreal, October 1-5 2024.
-
NewThe One Health Platform and MSD in Spain are launching an innovative and pioneering initia...
Universities interested in joining the 'One University, One Health' initiative are warmly welcome. The current members include the following members: Jaume I University of Castellón, UCAM of Murcia
-
NewNew Approach to Glycovaccines
IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose to produce new, more effective vaccines for immunotherapies.
-
NewBCN HEALTH has presented several communications at the EASL and AASLD congresses evaluatin...
The EASL congress took place between the 5th and the 8th of June in Milan, while the AASLD congress has taken place between the 15th and the 19th of November in San Diego.
-
NewAlira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030.
-
NewAlmirall launches The Hive, creating a novel collaborative innovation hub to advance life ...
Almirall announces the launch of "The Hive" an innovative scientific research hub, located at Almirall's R&D center in Barcelona, aims to foster collaboration among researchers from biotech companies
-
NewGENESIS Biomed consolidates its position as a key player in the growth and revitalisation...
GENESIS Biomed, which specialises in consultancy services for early-stage projects in the biomedical sector, will close 2024 with an accumulated turnover of 9 million euros since the start of activity
-
NewGloMax® Galaxy Bioluminescence Imager: Transforming Protein Dynamics Research
Promega has launched the GloMax® Galaxy Bioluminescence Imager, an innovative tool for visualizing protein dynamics in live cells using NanoLuc® technologies, eliminating the need for fluorescent
-
New#NewAseBioMember | “AseBio represents more than just an association; it's a catalyst for c...
Meet Pharmaron, our new member. We spoke with Javier Ruiz Sanz, Associate Director – Business Development.
-
New#NewAseBioMember | “AseBio is a biotechnology-related partnership that can serve to increa...
Meet Universidad de Córdoba, our new member. We spoke with Alejandro Rodríguez Pascual, General Director of Transfer and OTRI.